TY  - JOUR
AU  - Gámez-Chiachio, Manuel
AU  - Molina-Crespo, Ángela
AU  - Ramos-Nebot, Carmen
AU  - Martinez-Val, Jeannette
AU  - Martinez, Lidia
AU  - Gassner, Katja
AU  - Llobet, Francisco 
AU  - Soriano, Mario
AU  - Hernandez, Alberto
AU  - Cordani, Marco
AU  - Bernadó-Morales, Cristina
AU  - Diaz, Eva
AU  - Rojo-Sebastian, Alejandro
AU  - Triviño, Juan Carlos
AU  - Sanchez, Laura
AU  - Rodríguez-Barrueco, Ruth
AU  - Arribas, Joaquín
AU  - Llobet-Navás, David
AU  - Sarrió, David
AU  - Moreno Bueno, Gema
PY  - 2022
DO  - 10.1186/s13046-022-02497-w
SN  - 1756-9966
UR  - https://hdl.handle.net/20.500.14352/91630
T2  - Journal of Experimental & Clinical Cancer Research
AB  - Background: Gasdermin B (GSDMB) over-expression promotes poor prognosis and aggressive behavior in HER2 breast cancer by increasing resistance to therapy. Decoding the molecular mechanism of GSDMB-mediated drug resistance is crucial to identify novel...
LA  - eng
M2  - 1
PB  - Springer
KW  - Anti-HER2 therapy
KW  - Drug resistance
KW  - Gasdermin B
KW  - Gastroesophageal tumors
KW  - HER2 breast cancer
KW  - LC3B
KW  - Protective autophagy
TI  - Gasdermin B over-expression modulates HER2-targeted therapy resistance by inducing protective autophagy through Rab7 activation
TY  - journal article
VL  - 41
ER  -